JP2005511499A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511499A5 JP2005511499A5 JP2003523265A JP2003523265A JP2005511499A5 JP 2005511499 A5 JP2005511499 A5 JP 2005511499A5 JP 2003523265 A JP2003523265 A JP 2003523265A JP 2003523265 A JP2003523265 A JP 2003523265A JP 2005511499 A5 JP2005511499 A5 JP 2005511499A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- group
- seq
- nos
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 12
- 102000009366 Alpha-s1 casein Human genes 0.000 claims 10
- 108050000244 Alpha-s1 casein Proteins 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 9
- 238000004519 manufacturing process Methods 0.000 claims 9
- 102000036902 Thrombopoietin Human genes 0.000 claims 8
- 108010041111 Thrombopoietin Proteins 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 208000008425 Protein Deficiency Diseases 0.000 claims 6
- 210000001185 Bone Marrow Anatomy 0.000 claims 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 5
- 208000001756 Virus Disease Diseases 0.000 claims 4
- 206010003816 Autoimmune disease Diseases 0.000 claims 3
- 206010061590 Blood disease Diseases 0.000 claims 3
- 210000004443 Dendritic Cells Anatomy 0.000 claims 3
- 206010012601 Diabetes mellitus Diseases 0.000 claims 3
- 208000005209 Hematologic Disease Diseases 0.000 claims 3
- 210000002540 Macrophages Anatomy 0.000 claims 3
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims 3
- 201000009910 diseases by infectious agent Diseases 0.000 claims 3
- 230000002708 enhancing Effects 0.000 claims 3
- 230000002489 hematologic Effects 0.000 claims 3
- 201000002138 hematopoietic system disease Diseases 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 210000000130 stem cell Anatomy 0.000 claims 3
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 claims 2
- 210000004369 Blood Anatomy 0.000 claims 2
- 206010018687 Granulocytopenia Diseases 0.000 claims 2
- 210000003958 Hematopoietic Stem Cells Anatomy 0.000 claims 2
- 206010021425 Immune system disease Diseases 0.000 claims 2
- 206010024324 Leukaemias Diseases 0.000 claims 2
- 210000004698 Lymphocytes Anatomy 0.000 claims 2
- 210000000440 Neutrophils Anatomy 0.000 claims 2
- 206010033661 Pancytopenia Diseases 0.000 claims 2
- 206010062081 Plasma cell disease Diseases 0.000 claims 2
- 206010035534 Platelet disease Diseases 0.000 claims 2
- 206010043554 Thrombocytopenia Diseases 0.000 claims 2
- 206010047461 Viral infection Diseases 0.000 claims 2
- 201000010000 agranulocytosis Diseases 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 238000010322 bone marrow transplantation Methods 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000011132 hemopoiesis Effects 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 230000017613 viral reproduction Effects 0.000 claims 2
- 206010002967 Aplastic anaemia Diseases 0.000 claims 1
- 206010060945 Bacterial infection Diseases 0.000 claims 1
- 102000003951 Erythropoietin Human genes 0.000 claims 1
- 108090000394 Erythropoietin Proteins 0.000 claims 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 1
- 208000009576 Hypercholesterolemia Diseases 0.000 claims 1
- 206010062060 Hyperlipidaemia Diseases 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 1
- 210000004011 Plasma Cells Anatomy 0.000 claims 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 1
- 210000003283 T-Lymphocytes, Helper-Inducer Anatomy 0.000 claims 1
- 230000000735 allogeneic Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000007375 blood platelet disease Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 229940105423 erythropoietin Drugs 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 210000002443 helper T lymphocyte Anatomy 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 201000003793 myelodysplastic syndrome Diseases 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229920000023 polynucleotide Polymers 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 230000001105 regulatory Effects 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/942,121 US20020147144A1 (en) | 2000-03-01 | 2001-08-30 | Casein derived peptides and uses thereof in therapy |
| PCT/IL2002/000720 WO2003018606A2 (en) | 2001-08-30 | 2002-08-29 | Casein derived peptides and uses thereof in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005511499A JP2005511499A (ja) | 2005-04-28 |
| JP2005511499A5 true JP2005511499A5 (ko) | 2006-01-26 |
Family
ID=25477603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003523265A Pending JP2005511499A (ja) | 2001-08-30 | 2002-08-29 | カゼイン由来ペプチドおよびその医療用途 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1556074A4 (ko) |
| JP (1) | JP2005511499A (ko) |
| KR (1) | KR20040078639A (ko) |
| CN (1) | CN1694719A (ko) |
| AU (1) | AU2002324323A2 (ko) |
| BR (1) | BR0212625A (ko) |
| CA (1) | CA2458924A1 (ko) |
| CZ (1) | CZ2004335A3 (ko) |
| HU (1) | HUP0500995A3 (ko) |
| IL (1) | IL160548A0 (ko) |
| MX (1) | MXPA04001890A (ko) |
| NO (1) | NO20040880L (ko) |
| PL (1) | PL375113A1 (ko) |
| WO (1) | WO2003018606A2 (ko) |
| ZA (1) | ZA200401574B (ko) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
| US20050192312A1 (en) * | 2004-01-30 | 2005-09-01 | Brown Dennis M. | Naphthalimide dosing by N-acetyl transferase genotyping |
| US20070203060A1 (en) * | 2004-03-01 | 2007-08-30 | Zvi Sidelman | Casein Derived Peptides And Therapeutic Uses Thereof |
| GB0423352D0 (en) | 2004-10-21 | 2004-11-24 | Hannah Res Inst | "Control of mammary cell number" |
| ES2319475B1 (es) * | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
| JP4394155B2 (ja) | 2006-06-09 | 2010-01-06 | 森永乳業株式会社 | 脂質代謝改善剤 |
| JP2011026213A (ja) * | 2009-07-22 | 2011-02-10 | Snow Brand Milk Prod Co Ltd | １型糖尿病抑制ペプチド |
| JP2015520129A (ja) * | 2012-04-16 | 2015-07-16 | ザ クリーブランド クリニック ファウンデーション | 多価乳がんワクチン |
| AU2018227125A1 (en) * | 2017-03-03 | 2019-10-24 | Morinaga Milk Industry Co., Ltd. | GLP-1 secretagogue and composition |
| CN107814835B (zh) * | 2017-12-01 | 2020-04-28 | 熊猫乳品集团股份有限公司 | 一种生物活性多肽avpitptlnreq及其制备方法和应用 |
| CN108017709B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽kepmigvnqela及其制备方法和应用 |
| CN113952446B (zh) * | 2021-09-03 | 2023-12-05 | 河南省医药科学研究院 | 生物活性肽在抑制骨髓毒性中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3778426A (en) * | 1970-12-16 | 1973-12-11 | Research Corp | Therapeutically useful polypeptides |
| EP0922769A4 (en) * | 1997-03-21 | 2000-07-12 | Snow Brand Milk Products Co Ltd | HYDROLYSATE OF THE IRON-CASE COMPLEX AND A METHOD FOR ITS PRODUCTION. |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
-
2002
- 2002-08-29 CA CA002458924A patent/CA2458924A1/en not_active Abandoned
- 2002-08-29 WO PCT/IL2002/000720 patent/WO2003018606A2/en active Search and Examination
- 2002-08-29 CZ CZ2004335A patent/CZ2004335A3/cs unknown
- 2002-08-29 MX MXPA04001890A patent/MXPA04001890A/es not_active Application Discontinuation
- 2002-08-29 PL PL02375113A patent/PL375113A1/xx not_active Application Discontinuation
- 2002-08-29 IL IL16054802A patent/IL160548A0/xx unknown
- 2002-08-29 EP EP02758768A patent/EP1556074A4/en not_active Withdrawn
- 2002-08-29 BR BRPI0212625-7A patent/BR0212625A/pt not_active IP Right Cessation
- 2002-08-29 JP JP2003523265A patent/JP2005511499A/ja active Pending
- 2002-08-29 KR KR10-2004-7002884A patent/KR20040078639A/ko not_active Application Discontinuation
- 2002-08-29 CN CNA028216741A patent/CN1694719A/zh active Pending
- 2002-08-29 AU AU2002324323A patent/AU2002324323A2/en not_active Abandoned
- 2002-08-29 HU HU0500995A patent/HUP0500995A3/hu unknown
-
2004
- 2004-02-26 ZA ZA200401574A patent/ZA200401574B/en unknown
- 2004-02-27 NO NO20040880A patent/NO20040880L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003528827A5 (ko) | ||
| JP2008509073A5 (ko) | ||
| Pachón-Ibáñez et al. | Perspectives for clinical use of engineered human host defense antimicrobial peptides | |
| US7183381B2 (en) | Composition of lactoferrin related peptides and uses thereof | |
| JP2005511499A5 (ko) | ||
| WO2007022537A2 (en) | Use of lactoferrin as a chemokine and a chemotactic modulator | |
| EP2091568A2 (en) | Fusion proteins comprising a anti-inflammatory cytokine and an antigen for treatment of immune disorders | |
| WO2009028943A1 (en) | Mutants of lactoferrin | |
| US20160122391A1 (en) | Short beta-defensin-derived peptides | |
| WO2002080958A1 (fr) | Interferon supercompose de recombinaison utilise comme inhibiteur de l'antigene de surface et de l'antigene e de l'hepatite b | |
| WO2021126929A1 (en) | Modified interferon-alpha-2 having reduced immunogenicity | |
| Hartung | Immunomodulation by colony-stimulating factors | |
| JPH09289896A (ja) | 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質 | |
| US10548946B2 (en) | Therapeutic compositions for neutralizing type I interferons, and methods of use | |
| WO2005018542A2 (en) | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects | |
| EP2535057A2 (en) | Compositions for the treatment of infectious and tumoural diseases | |
| KR20210129282A (ko) | 변형된 인터루킨-7 단백질 및 이의 용도 | |
| US6593457B1 (en) | Lymphocyte-derived antimicrobial protein (LDAP) and methods of isolating and producing and using the protein | |
| JPH03236400A (ja) | 化学修飾ポリペプチド及びその用途 | |
| AU660942B2 (en) | Ovine cytokine genes | |
| Unanue | Innate immunity in bacterial infections | |
| JP5699093B2 (ja) | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 | |
| Ghosh et al. | Human granulocyte-macrophage colony-stimulating factor: The protein and its current & emerging applications | |
| CA2320959C (en) | Cytokine inducers comprising m161ag | |
| CN1231258C (zh) | 一种口含干扰素冰块及其制法 |